NovoCure · raw details

Treatment of Brain Tumors Using Electric Fields · Haifa · Founded 1999

active Public ← back to profile

Highlights

IIA supported (ever)1 patent

About

Treatment of Brain Tumors Using Electric Fields

Novocure is a commercial-stage oncology company developing a novel, proprietary therapy called Tumor Treating Fields, or TTFields, for the treatment of solid tumor cancers.

TTFields are low-intensity, intermediate-frequency alternating electric fields that disrupt mitosis and cytokinesis. TTFields exert sufficient physical force on charged cellular components to stop normal cell-division processes, specifically the formation of the mitotic spindle from tubulin dimer proteins. TTFields also exert a physical force on other components of the cell during division, causing cell death prior to division.

TTFields therapy is delivered using noninvasive, insulated transducer arrays that are placed directly on the skin in the region surrounding the tumor. The complete delivery system includes a portable electric field generator, transducer arrays, rechargeable batteries, and more. The portable therapy is designed to be worn continuously throughout the day and night.

Novocure received an FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small cell lung cancer.

Identity

NameNovoCure
Slugnovocure
Type / kindstartup
Crunchbase IDnovocure
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6HwuQJDA

Status

Statusactive
Status reasonPublic on NASDAQ on Oct, 2015<br>
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtNorth District
HQ cityHaifa
HQ addressMatam Center, Haifa, Israel

Web & social

Websitehttps://www.novocure.com
Careers pagehttps://www.novocure.com/careers
LinkedInhttps://www.linkedin.com/company/105770
Twitter / Xhttps://twitter.com/novocure
YouTubehttps://www.youtube.com/channel/UCuzA71KFInZJKm9B24mBJZQ

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business models
B2B
Tags
cell-therapycancernon-invasivemedical-technologieschemotherapyoncologypharmaceuticalstreatmentswearable

Funding

Total raised$742.0M
Current stagePublic
Market cap$1.4B

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}